These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11592528)

  • 1. Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma.
    Wheeler LA; Woldemussie E
    Eur J Ophthalmol; 2001; 11 Suppl 2():S30-5. PubMed ID: 11592528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of alpha-2 agonists in neuroprotection.
    Wheeler L; WoldeMussie E; Lai R
    Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S47-51. PubMed ID: 12852434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma.
    Wheeler LA; Gil DW; WoldeMussie E
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S290-4; discussion S295-6. PubMed ID: 11377451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
    Ahmed FA; Hegazy K; Chaudhary P; Sharma SC
    Brain Res; 2001 Sep; 913(2):133-9. PubMed ID: 11549376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury.
    Wheeler LA; Lai R; Woldemussie E
    Eur J Ophthalmol; 1999; 9 Suppl 1():S17-21. PubMed ID: 10230601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
    Yoles E; Wheeler LA; Schwartz M
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells.
    Gao H; Qiao X; Cantor LB; WuDunn D
    Arch Ophthalmol; 2002 Jun; 120(6):797-803. PubMed ID: 12049586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
    WoldeMussie E; Ruiz G; Wijono M; Wheeler LA
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
    Hernández M; Urcola JH; Vecino E
    Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
    Dong CJ; Guo Y; Agey P; Wheeler L; Hare WA
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4515-22. PubMed ID: 18566471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use.
    Cantor LB
    Expert Opin Pharmacother; 2000 May; 1(4):815-34. PubMed ID: 11249518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection.
    Levkovitch-Verbin H; Harris-Cerruti C; Groner Y; Wheeler LA; Schwartz M; Yoles E
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4169-74. PubMed ID: 11095611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brimonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death.
    Vidal-Sanz M; Lafuente MP; Mayor-Torroglosa S; Aguilera ME; Miralles de Imperial J; Villegas-Pérez MP
    Eur J Ophthalmol; 2001; 11 Suppl 2():S36-40. PubMed ID: 11592529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model.
    Ma K; Xu L; Zhang H; Zhang S; Pu M; Jonas JB
    Am J Ophthalmol; 2009 Feb; 147(2):326-31. PubMed ID: 18835468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy.
    Danylkova NO; Alcala SR; Pomeranz HD; McLoon LK
    Exp Eye Res; 2007 Feb; 84(2):293-301. PubMed ID: 17113077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model.
    Aktaş Z; Gürelik G; Akyürek N; Onol M; Hasanreisoğlu B
    Clin Exp Ophthalmol; 2007 Aug; 35(6):527-34. PubMed ID: 17760634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effects of Human Serum Albumin Nanoparticles Loaded With Brimonidine on Retinal Ganglion Cells in Optic Nerve Crush Model.
    Kim KE; Jang I; Moon H; Kim YJ; Jeoung JW; Park KH; Kim H
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5641-9. PubMed ID: 26313300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model.
    Zhou X; Zhang T; Wu J
    Exp Eye Res; 2019 Dec; 189():107833. PubMed ID: 31618613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal ganglion cell death induced by retinal ischemia. neuroprotective effects of two alpha-2 agonists.
    Vidal-Sanz M; Lafuente MP; Mayor S; de Imperial JM; Villegas-Pérez MP
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S261-7; discussion S273-6. PubMed ID: 11377446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study.
    Lafuente MP; Villegas-Pérez MP; Mayor S; Aguilera ME; Miralles de Imperial J; Vidal-Sanz M
    Exp Eye Res; 2002 Feb; 74(2):181-9. PubMed ID: 11950228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.